Matica Biotechnology, Inc.’s Post

If you are attending #NBC2024 of AAPS, I will be discussing with the industry leaders in Cell & Gene Therapies about the current challenges and opportunities in the panel section hosted by Praveen Tyle, especially the market access and development in the rare disease space. Look forward to the discussion!

The University of Eastern Finland and the biotechnology company FinVector Oy have signed a memorandum of understanding committing the two to a long-term strategic partnership and to further development of collaboration. The memorandum of understanding will intensify the already close collaboration between the university and FinVector by making it increasingly systematic and goal-oriented. The partnership will be strengthened by expanding collaboration from research to also include worklife and educational collaboration. https://lnkd.in/gvFqyf93

Researchers at the Massachusetts Institute of Technology (MIT) and the Dana-Farber Cancer Institute have developed a groundbreaking approach utilising machine learning to address the challenge of identifying the origins of enigmatic cancers. Employing a computational model, the scientists have devised a method to analyse the genetic sequence of approximately 400 genes, which can predict the source of a given tumour within the body. Read more at https://bit.ly/3MLZ4Oe #lbs #lbs24 #londonbiotechnologyshow #biotechnology #medtech #innovation #bioinformatics #agriculture #bioengineering #innovation #lifesciences #bioenergy #genetics

Helix's CEO, Josh Carter, is participating at the American Crystallographic Association's 74th Annual Meeting in Denver, Colorado, from July 7-12, 2024. Day 4 has been filled with valuable networking opportunities and insightful presentations in areas such as protein flexibility and drug design, data analysis for structural elucidation, and MicroED for small molecules. Two fantastic presentations included “Structure Determination of Difficult to Grow Active Pharmaceutical Ingredients (APIs) using MicroED” by AbbVie, and “Structure determination by NMR Crystallography, from microcrystalline powders to amorphous molecular solids” by EPFL (Switzerland). And the poster sessions also continue to showcase groundbreaking research! If you are at the conference, Josh would be delighted to connect, discuss science, and exchange insights. He looks forward to sharing how his and Helix's expertise excels in overcoming challenges and advancing projects. Did you know that our Cryo-EM and X-ray services can help you gain unprecedented insights into the structural details of your biological entity of interest, whether wild-type or mutated? Call us today and get the peace of mind you deserve! (https://loom.ly/S6ImyLI) #cryoem #crystallization #crystallography #drugdiscovery #drugdesign #protein #proteins #dna #rna #antibody #antibodies #science #nature #research #bio #bionetwork #biotechnology #biotech #bioscience #biotechnologyindustry #biopharma #drugdesign #drugdevelopment #pharmaceuticals #pharma #drug #lifesciences #lifescience

🎉 We are excited to announce the expansion of Twist Express Genes to include midiprep and maxiprep! From click to ship in as few as 5️⃣ days and still NGS-verified & clonally perfect. “Since the initial launch of our Express Genes service in November, we have received positive and enthusiastic feedback from existing customers on our consistent and rapid turnaround time. By expanding Express Genes to include midiprep and maxiprep, we can now offer rapid gene synthesis at all gene prep scales, enabling large scale experimentation for pharmaceutical, biotechnology, academic and industrial chemical researchers,” said Emily Leproust, CEO and co-founder of Twist Bioscience. “With the expanded offering of Twist Express Genes, more researchers can gain access to Twist genes fast and at scale, including those using alternative providers and those cloning their own genes. The ability to order and receive synthetic DNA fast and at scale means more time for cutting-edge research, more make-test-learn cycles, and an accelerated journey to game-changing discoveries.” Read more here: https://lnkd.in/gEqatwSr Product information: https://lnkd.in/g7d-zQvp Twist Bioscience, #gene #genes #DNA #WeMakeDNA

NGS-based RNA-sequencing Market Is Poised to Reach $5.5 Billion by 2027 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dqQwviT4 NGS-based RNA-sequencing Market in Terms of Revenue Was Estimated to Be Worth $2.5 Billion in 2022 and Is Poised to Reach $5.5 Billion by 2027, Growing at a Cagr of 17.2% From 2022 to 2027. Illumina QIAGEN PerkinElmer, Inc. Eurofins Scientific Finland Oy Oxford Nanopore Technologies Agilent Technologies BGI Group GENEWIZ, By Azenta Life Sciences Hamilton Company Nugen Technologies (Pty) Ltd Psomagen F. Hoffmann-La Roche Ltd Thermo Fisher Scientific Takara Bio USA, Inc. PACIFIC BIOSCIENCES OF CALIF Zymo Research Corp Lucigen Corp. Genotypic Technology OXFORD GENE TECHNOLOGY LIMITED Becton, Dickinson and Company

NGS-based RNA-sequencing Market Is Poised to Reach $5.5 Billion by 2027 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dqQwviT4 NGS-based RNA-sequencing Market in Terms of Revenue Was Estimated to Be Worth $2.5 Billion in 2022 and Is Poised to Reach $5.5 Billion by 2027, Growing at a Cagr of 17.2% From 2022 to 2027. Illumina QIAGEN PerkinElmer, Inc. Eurofins Scientific Finland Oy Oxford Nanopore Technologies Agilent Technologies BGI Group GENEWIZ, By Azenta Life Sciences Hamilton Company Nugen Technologies (Pty) Ltd Psomagen F. Hoffmann-La Roche Ltd Thermo Fisher Scientific Takara Bio USA, Inc. PACIFIC BIOSCIENCES OF CALIF Zymo Research Corp Lucigen Corp. Genotypic Technology OXFORD GENE TECHNOLOGY LIMITED Becton, Dickinson and Company

Genflow Biosciences (LON:GENF) (OTCQB:GENFF) chief executive officer Dr. Eric Leire spoke with Proactive's Stephen Gunnion to discuss the impact of two substantial research grants awarded to Genflow in Belgium. These grants are not just financial boons but are fostering critical collaborations in the field of advanced therapy medicinal products (ATMPs), marking a new era in biotechnological research and development.  Stephen Gunnion (SG): Dr. Leire, can you elaborate on the scope of these grants and their importance for Genflow Biosciences? More at #Proactive #ProactiveInvestors #LSE #OTCQB #GENF #GENFF #GenflowBioscience #researchgrant #ATMP #antiaging #longerlife http://ow.ly/IiVg105cOpI

Maryland, Together With D.C and Virginia, Now a “Top 3” Biopharma Cluster "The latest rankings from Genetic Engineering & Biotechnology News included some long-awaited good news for Maryland: the Biohealth Capital Region had moved up to No. 3 on the publication’s list of the top ten biopharma clusters in the United States. Leaders in Maryland’s biohealth industry have been working to make the BHCR a “Top 3 by 2023” since back in 2016. In recent years, the region (comprising Maryland, Virginia and Washington, D.C.) has ranked No. 4."